About Pablo Prichard
Form D filings for SEngine Precision Medicine in 2023 list Pablo Prichard as director.
Pablo Prichard first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Pablo Prichard in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Pablo Prichard works with at each company, as listed on that company's latest Form D.
SEngine Precision Medicine, Inc. · Form D, Mar 10, 2023
CK
Christopher Kemp
Executive officer and promoter
TH
Tony Hsu
Executive officer
EB
Elliott Burkland
Director
CG
Carla Grandori
President and CEO, director